Fig. 3From: IGF2BP3 (IMP3) expression in angiosarcoma, epithelioid hemangioendothelioma, and benign vascular lesionsIGF2BP3 (IMP3) is negative or equivocally expressed in pathological samples of benign vascular lesions; four representative cases are presented here. Immunohistochemistry (× 100 and × 600)Back to article page